Drugs / Bupivacaine hydrochloride (HCl)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04278846 Comparator | Aug 2014 → Dec 2017 | neuropathy, painful | The Cleveland Clinic | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bupivacaine hydrochloride (HCl) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04278846 ↗ |
| Route | Other | “The study drug bupivacaine HCl will be administered into the right and/or left breast of each patient 30 minutes prior to the creation of the subpectoral muscle pocket.” NCT04278846 ↗ |